Lanthanum comment watch save
BreastfeedingPediatric

  • TRADE NAME: Fosrenol (Shire)
  • INDICATIONS: Hyperphosphatemia in end-stage renal disease
  • CLASS: Chelator
  • HALF-LIFE: 53 hours

Contra-indicated in patients with bowel obstruction, ileus, and/or fecal impaction.

Please login to view the rest of this drug profile.

    DRUG REVIEW ARTICLE

    (Note that non-subscribers to the journal will only be able to see an abstract of the article.)

Page last updated 01/04/2025

Symbol key

Incidence

<1% 1‑5% 5‑10% 10‑15% 15‑20% 20‑30% >30%

Seriousness

Hospitalization possible
Life threatening
Fatal

Warnings in other populations

BreastfeedingBreast feeding

GeriatricGeriatric

PediatricPediatric

Back to top